CASTLE BIOSCIENCES INC
For the period ended May 2, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 2, 2024 · Filed May 2, 2024
Use the contents to explore the available documents and sections.
CSTL$32.52-4.9%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| NET REVENUES | $72,974 | $42,037 |
| OPERATING EXPENSES | ||
| Cost of sales (exclusive of amortization of acquired intangible asset) | 13,894 | 10,182 |
| Research and development | 13,809 | 14,393 |
| Selling, general and administrative | 48,495 | 46,762 |
| Amortization of acquired intangible asset | 2,247 | 2,222 |
| Total operating expenses, net | 78,445 | 73,559 |
| Operating loss | (5,471) | (31,522) |
| Interest income | 2,996 | 2,336 |
| Interest expense | (14) | (4) |
| Loss before income taxes | (2,489) | (29,190) |
| Income tax expense | 45 | 14 |
| Net loss | $(2,534) | $(29,204) |
| Loss per share, basic and diluted | $(0.09) | $(1.10) |
| Weighted-average shares outstanding, basic and diluted | 27,485 | 26,607 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.